Skip to main content
Journal of Experimental & Clinical Cancer Research : CR logoLink to Journal of Experimental & Clinical Cancer Research : CR
. 2024 Aug 29;43:244. doi: 10.1186/s13046-024-03170-0

Correction: TFEB controls sensitivity to chemotherapy and immuno-killing in non-small cell lung cancer

Muhlis Akman 1, Ciro Monteleone 1, Gabriella Doronzo 1,2, Martina Godel 1,8, Francesca Napoli 3, Alessandra Merlini 4, Virginia Campani 5, Valeria Nele 5, Elisa Balmas 6,8, Tatiana Chontorotzea 7, Simona Fontana 1,8, Sabrina Digiovanni 1,8, Francesca Alice Barbu 3, Elena Astanina 2, Niloufar Jafari 1,8, Iris Chiara Salaroglio 1,8, Joanna Kopecka 1,8, Giuseppe De Rosa 5, Thomas Mohr 7, Alessandro Bertero 6,8, Luisella Righi 3, Silvia Novello 4, Giorgio Vittorio Scagliotti 4, Federico Bussolino 1,2, Chiara Riganti 1,8,
PMCID: PMC11360497  PMID: 39198838

Correction: J Exp Clin Cancer Res 43, 219 (2024)

https://doi.org/10.1186/s13046-024-03142-4

Following publication of the original article [1], the authors found out errors pertaining on the affiliations of the authors. The changes requested are highlighted in bold.

• Affiliation 2 should be changed from: “IRCCS Candiolo Cancer Institute, Candiolo, Italy” to “Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy”.

• Affiliation 5 should be updated from: “Department of Pharmacy, University of Napoli “Federico II”, Napoli, Italy” to “Department of Pharmacy, University of Napoli Federico II, Napoli, Italy”.

• Affiliation 7 should be updated from: “Medical University of Vienna, Vienna, Austria” to “Center for Cancer Research and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria”.

These corrections do not affect the overall result or conclusion of the article. The original article [1] has been corrected.

Footnotes

The online version of the original article can be found at 10.1186/s13046-024-03142-4.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Akman M, Monteleone C, Doronzo G, et al. TFEB controls sensitivity to chemotherapy and immuno-killing in non-small cell lung cancer. J Exp Clin Cancer Res. 2024;43:219. 10.1186/s13046-024-03142-4. 10.1186/s13046-024-03142-4 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Experimental & Clinical Cancer Research : CR are provided here courtesy of BMC

RESOURCES